Patient Registry Software Market Size, Share, and Industry Analysis, By Registry Type (Disease Registry, Health Registry, Population Registry, and Others), By Functionality (Population Health Management, Medical Research and Clinical Studies, Health Information Exchange, Patient Care Management, and Others), By End User (Hospitals & ASCs, Diagnostics Centers, Specialty Clinics, and Others), and Regional Forecast, 2026-2034

Last Updated: March 16, 2026 | Format: PDF | Report ID: FBI114787

Patient Registry Software Market Size & Future Outlook

The global patient registry software market size was valued at USD 2.50 billion in 2025. The market is projected to grow from USD 2.77 billion in 2026 to USD 6.39 billion by 2034, exhibiting a CAGR of 11.00% during the forecast period.

The global patient registry software market is expected to grow with a significant CAGR over the forthcoming years due to the increasing focus on advanced analytics and technology integration for efficient data management to enhance patient care and streamline the research and clinical trial process.

These factors have led to the increasing adoption of patient registry software by governments and hospitals for public health monitoring and policy development. Furthermore, various strategic collaborations between operational entities in the market are expected to contribute to the market growth.

For instance, in January 2022, IQVIA collaborated with the GO2 Foundation for Lung Cancer to develop an improved Global Lung Cancer Registry. This registry collected data from patients across the globe and provided researchers and patients with access. Data collected through registries assisted researchers in identifying the trends in a clinical trial.

Patient registries are defined as an organized system that uses observational study methods to collect uniform data to evaluate specified outcomes for a population defined by a particular disease, condition, or exposure, and that serves a predetermined scientific, clinical, or policy purpose. Software facilitating patient registries provides insights to healthcare providers, pharmaceutical companies, and researchers for various applications by monitoring disease prevalence and disease outcomes in various studies.

Patient Registry Software Market Driver

Various Initiatives by the Government to Promote the Adoption of Patient Registry Software to Drive Market Growth

Favorable initiatives by the global government to promote the Adoption of digitalization of health records and enhanced patient registry to drive the market growth. Patient registry software is increasingly used by governments worldwide for various purposes, including post-marketing surveillance and management of drugs and medical devices.

Furthermore, various government and private partnerships to support patient registries are expected to propel market growth.

For instance, in June 2025, the European Cystic Fibrosis Society (ECFS), in cooperation with the ECFS Patient Registry (ECFSPR), opened applications to join the ECFSPR-Partnership project. This project aimed to support Cystic Fibrosis (CF) patient registries for low- and middle-income countries (LMICs) outside the WHO European Region.
Similarly, in January 2025, State Health Minister Veena George of Kerala announced the launch of a rare disease patient registry and treatment clinic in India.

Additionally, the rise in clinical trials for drug discovery of novel therapeutics augments the demand for effective patient registry software for data management for research analysis. Such developments are expected to propel the growth of the global patient registry software market.

Total Patient Registration by Region in Prince Edward Province, Canada, in January 2025

The Provincial Patient Registry in Prince Edward Island province, Canada, reported 37,379 registries in the region, with the most registries done in Queens with 17,524 registries.

Patient Registry Software Market Restraint

High Prices Associated with the Deployment of Patient Registry Software May Hamper Its Adoption

The Patient Registry Software requires a highly interoperable IT infrastructure with other integrated health systems. This skyrockets the deployment prices of such software. Such high prices associated with deploying registry software may hamper product adoption and restrict market growth.

For instance, in April 2025, Octal IT Solution published a blog reporting that, on average, the development cost for a basic patient registry software system ranged from USD 50,000 to USD 250,000. The more advanced systems were marked from USD 500,000 to USD 1.0 million.

Patient Registry Software Market Opportunity

Technological Advancements to Combat Data Security Concerns and Support Market Growth

The global patient registry software market has witnessed numerous technological advancements, such as blockchain, to combat data breaches and security concerns associated with patient registry software. Various key players are integrating this blockchain technology for enhanced security. Such developments result in broader Adoption of these technologies and catalyze the market growth.

For instance, in May 2024, Rymedi partnered with Precision Genetics to transform health outcomes and efficiencies through precision medicine. The collaboration combined Precision Genetics' PrecisionOp and Rymedi's blockchain-enabled clinical trial and registry platform to reduce adverse drug reactions and reliance on post-operative opioids for surgery patients.

Key Insights

The report covers the following key insights:

Technological Advancement in the Market
Overview- Application of Patient Registry Software
Different Patient Registries- By Key Countries/ Regions
New Product Launches
Key Industry Development- Mergers, Acquisitions, Partnerships, Others

Segmentation

By Registry Type	By Functionality	By End User	By Region
Disease Registry Health Services Registry Population Registry Others	Population Health Management Health Information Exchange Patient Care Management Medical Research and Clinical Studies Others	Hospitals & ASCs Diagnostics Centers Specialty Clinics Others	North America (U.S. and Canada) Europe (U.K., Germany, France, Spain, Italy, Scandinavia, and Rest of Europe) Asia Pacific (Japan, China, India, Australia, Southeast Asia, and Rest of Asia Pacific) Latin America (Brazil, Mexico, and Rest of Latin America) Middle East & Africa (South Africa, GCC, and Rest of Middle East & Africa)

Analysis by Registry Type

By registry type, the market is divided into disease registry, health registry, population registry, and others.

The disease registry segment is expected to hold a substantial market share in the global patient registry software market. This patient registry software collects information regarding various conditions and their therapies and enhances understanding of disease progression, symptoms, and management. Data is collected from the registered patients and collected by clinicians, or automatically collected through wearable devices. Various key players are focusing on new product launches to enhance disease monitoring and predictive diagnosis. Such developments are expected to boost the segment's growth in the market.

For instance, in June 2025, Artera launched its DIRECT-AI registry study. This study assessed the influence of the ArteraAI Prostate Test on treatment for enhanced decision-making between clinicians and patients with localized prostate cancer. The study also monitored the participants and evaluated the long-term outcomes. This development reinforced the company's commitment to advancements in cancer treatments.

Analysis by Functionality

By functionality, the market is divided into population health management, medical research and clinical studies, health information exchange, patient care management, and others.

The medical research and clinical studies are expected to hold a considerable market share in the global patient registry software market. The segmental growth is accredited to rising investments in novel therapeutics and ongoing research for rare diseases and cancers. Such developments heighten the demand for patient registry software for medical research and clinical studies, thus influencing market growth.

For instance, in December 2024, myTomorrows, added the ISRCTN registry to the clinical trial search functionality on its platform. With this update, the platform sourced from WHO-endorsed public registries, including clinicaltrials.gov, EudraCT, and ISRCTN, provides one of the comprehensive and unbiased search platforms worldwide and covers clinical trials globally.

Analysis by End User

By end user, the market is divided into hospitals & ASCs, diagnostics centers, specialty clinics, and others.

Hospitals & ASCs are expected to hold a substantial market share in the global market. These institutions are medical practitioners' first point of contact for patient care, to collect data, and to enroll patients in registries. Thus leading to increased adoption of this software in hospital and ASCs settings.

Furthermore, the segmental growth is attributed to various strategic initiatives, such as partnerships and collaborations by key operating entities to propel the adoption of patient registry software and enhance the knowledge base.

For instance, in August 2020, the Medical University of South Carolina joined the national patient registry to develop a knowledge base for COVID-19. To establish this objective, the National COVID Cohort Collaborative, or N3C, created a centralized national registry of patients tested or treated for COVID-19. Participating hospitals were instructed to provide COVID-19 patient data twice weekly to keep the registry current.

Regional Analysis

By region, the market is divided into North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America.

Request for Customization to gain extensive market insights.

North America accounted for the largest global patient registry market share in 2024. The market growth in the region is credited to a robust healthcare IT infrastructure and comparatively better documentation of health records. Such factors heighten the need for patient registry software to track disease progression, treatment outcomes & long-term management strategies and support the growth of the patient registry market.

For instance, in February 2025, Veradigm launched a disease-specific cardiometabolic Clinical Data Registry dataset. The dataset contained de-identified information about patients' health and care for a specific condition or disease. Such datasets provide researchers access to specialty, Natural Language Processing (NLP)-enhanced real-world data to advance the understanding of patient insights and clinical details to support research throughout the drug development life cycle.

Europe is the second-largest market based on the demand for patient registry software. The region's substantial market share is due to various national registry programs, collaboration with other prominent players, high accuracy in predictive analysis, and new product launches.

For instance, in May 2025, Inspire Medical Systems launched the EuroStim registry in Europe. It marked a key milestone toward enrolling 1,000 patients across Europe.

Asia Pacific is also expected to grow with a significant CAGR in the global patient registry software market. The growth in the region is attributed to various government initiatives to digitalize health records and provide value-added care to patients.

For instance, in August 2024, the South Korean government linked health records of 8.0 million patients to MyHealthway and streamlined access to the personal health records held in tertiary general hospitals in a single platform.

Key Players Covered

The global patient registry software market is fragmented, with a large number of group and standalone providers.

The report includes the profiles of the following key players:

Oracle (U.S.)
IQVIA (U.S.)
interActive Systems Berlin (Germany)
RAYLYTIC Software GmbH (Germany)
Veradigm LLC (U.S.)
Access Healthcare (India)
ScienceSoft USA Corporation. (U.S.)
Medical Information Technology, Inc. (U.S.)
Halemind Inc. (U.S.)
NXGN Management, LLC. (U.S.)
BizData Pty Ltd (Australia)

Key Industry Developments

In April 2025, Elekta partnered with Azra AI to improve cancer registry workflows using AI-powered automation. The partnership combined Elekta's next-generation software, Elekta ONE Registry Informatics, hosted on Axis Cloud, with Azra AI's oncology workflow tools. This collaboration aimed to streamline data management and ensure compliance with international standards.
In February 2025, Harmony Healthcare IT launched an AI-powered platform, ClearWay, to automate the clinical abstraction and submission process. ClearWay automates these administrative tasks, allows healthcare providers to dedicate more time to patient care, and enhances operational efficiency.
In April 2024, Synchron launched a community-centered BCI registry to facilitate information exchange between patients, caregivers, and clinicians and prepare for the next stage of clinical trials.
In November 2020, the American Academy of Pediatrics partnered with ArborMetrix to develop an advanced clinical registry for the well-being and development of all children.